Goldman Sachs’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Sell |
941,916
-11,915
| -1% | -$423K | ﹤0.01% | 1399 |
|
|
2025
Q1 | $32.4M | Sell |
953,831
-1,538,840
| -62% | -$52.2M | 0.01% | 1346 |
|
|
2024
Q4 | $81.1M | Buy |
2,492,671
+2,035,727
| +446% | +$66.2M | 0.01% | 775 |
|
|
2024
Q3 | $22.3M | Sell |
456,944
-211,046
| -32% | -$10.3M | ﹤0.01% | 1655 |
|
|
2024
Q2 | $29.6M | Buy |
667,990
+357,582
| +115% | +$15.8M | 0.01% | 1298 |
|
|
2024
Q1 | $17.4M | Sell |
310,408
-212,259
| -41% | -$11.9M | ﹤0.01% | 1647 |
|
|
2023
Q4 | $31.4M | Buy |
522,667
+260,899
| +100% | +$15.7M | 0.01% | 1250 |
|
|
2023
Q3 | $17.6M | Sell |
261,768
-127,433
| -33% | -$8.56M | ﹤0.01% | 1604 |
|
|
2023
Q2 | $26.9M | Buy |
389,201
+133,215
| +52% | +$9.2M | 0.01% | 1337 |
|
|
2023
Q1 | $12.3M | Buy |
255,986
+49,583
| +24% | +$2.39M | ﹤0.01% | 1849 |
|
|
2022
Q4 | $10.3M | Sell |
206,403
-350,255
| -63% | -$17.5M | ﹤0.01% | 2110 |
|
|
2022
Q3 | $22.7M | Buy |
556,658
+138,330
| +33% | +$5.64M | 0.01% | 1507 |
|
|
2022
Q2 | $23M | Buy |
418,328
+51,464
| +14% | +$2.83M | 0.01% | 1521 |
|
|
2022
Q1 | $13.3M | Buy |
366,864
+147,830
| +67% | +$5.37M | ﹤0.01% | 2000 |
|
|
2021
Q4 | $10.2M | Buy |
219,034
+144,190
| +193% | +$6.72M | ﹤0.01% | 2257 |
|
|
2021
Q3 | $3.78M | Buy |
74,844
+21,087
| +39% | +$1.07M | ﹤0.01% | 2984 |
|
|
2021
Q2 | $2.21M | Buy |
53,757
+45,395
| +543% | +$1.86M | ﹤0.01% | 3431 |
|
|
2021
Q1 | $243K | Sell |
8,362
-6,121
| -42% | -$178K | ﹤0.01% | 4749 |
|
|
2020
Q4 | $408K | Buy |
+14,483
| New | +$408K | ﹤0.01% | 3937 |
|